Nathan Weinstein

Nathan Weinstein

Director – Healthcare Analyst
Mr. Weinstein, CFA, began his career as an analyst intern at NGN Capital, a life sciences focused venture capital firm. Mr. Weinstein went on to work at Sidoti & Company and CL King & Associates. At those firms, Mr. Weinstein was involved with institutional equities, actively facilitating the distribution of equity research to investors including pension, mutual, and hedge-funds. Mr. Weinstein provided his clients with long/short idea flow, proprietary surveys, corporate access and conferences and led a successful business development effort that on boarded a significant number of new clients. Mr. Weinstein graduated from Binghamton University with degrees in Economics and English.

Companies Covered (By Industry)

BioTechnology

DARE Dare Bioscience, Inc.
STML Stemline Therapeutics Inc.
SCYX SCYNEXIS

Animal Health

KIN Kindred Biosciences

Medical Devices

AVGR Avinger, Inc.
DYNT Dynatronics
EKSO Ekso Bionics

Biopharmaceuticals

AMRN Amarin Corporation plc.

Pharmaceuticals

ACST Acasti Pharma Inc.

Agriculture

MBII Marrone Bio Innovations